| (CAD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -20.18M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EPRX.TO returned +37.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -2.6% |
| 1 year | +37.2% |
| 5 years | +235.0% |
| All-time high | $11.25 (Jan 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in EPRX.TO would be worth today ›No. Eupraxia Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
Eupraxia Pharmaceuticals Inc. is part of the Healthcare sector.
Eupraxia Pharmaceuticals Inc. has a market cap of 664.04M CAD, based on the latest quote.
Eupraxia Pharmaceuticals Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
